Results 11 to 20 of about 18,287 (255)
Preparation and Characterization of Desmopressin Peptide Attached Multi-Walled Carbon Nanotube [PDF]
Trends in Peptide and Protein Sciences, 2019 Desmopressin, a synthetic analogue of vasopressin, has many applications in medicine including diabetes insipidus, night bedwetting, and hemophillia A. In this work, the attachment of desmopressin to multi-walled carbon nanotubes (MWCNTs), functionalized
Mohammadreza Gholibeikian +2 more
doaj +3 more sources
Short Term Effect and Safety of Antidiuretic Hormone in the Patients with Nocturia [PDF]
International Neurourology Journal, 2010 Purpose To investigate the short-term safety of antidiuretic hormone in elderly patients with nocturnal polyuria, focus on hyponatremia and others electrolytes disturbances and to assess short-term effects on nocturnal urine output and number of ...
Dong Il Kang +5 more
doaj +5 more sources
Desmopressin for bedwetting. [PDF]
Archives of Disease in Childhood, 1992 Richard E. Morton, Michelle V. Daniels
+7 more sources
Desmopressin in nocturnal enuresis. [PDF]
Archives of Disease in Childhood, 1982 The response of desamino-D-arginine vasopressin (DDAVP) was investigated in 32 enuretic children in a double-blind clinical study. The 15 children treated with DDAVP showed a significant reduction in the incidence of bed wetting--from 18.7 +/- 6.5 to 6.5 +/- 9.2 wet nights per 30 days.
M Aladjem +5 more
openalex +5 more sources
Drugs, 2005 Desmopressin, a synthetic antidiuretic hormone analogue, is the only drug currently approved for the treatment of nocturia associated with nocturnal polyuria or multiple sclerosis (MS). Compared with vasopressin, desmopressin has a longer lasting and more potent antidiuretic effect and is devoid of vasopressor and uterotonic effects.
Gunnar Lose
openalex +4 more sources
Concurrent Thyroid Storm From Postpartum Thyroiditis and Lymphocytic Hypophysitis: A Rare Case. [PDF]
Clin Case RepABSTRACT Postpartum autoimmune thyroiditis (PAT) and lymphocytic hypophysitis (LH) are rare autoimmune conditions occurring during or after pregnancy. We present a case of a 35‐year‐old woman who developed thyroid storm because of PAT followed by LH, resulting in panhypopituitarism.
Wannaphut C +3 more
europepmc +2 more sources
Delay in desmopressin therapy: Disaster in waiting
Journal of Clinical Pharmacy and Therapeutics, Volume 47, Issue 12, Page 2376-2378, December 2022., 2022 There is little information on the onset of hypernatremia after withdrawal of desmopressin. We present a case of an elderly woman with central DI whose serum sodium jumped from 141 to 171 mEq/L after 48‐72 h of holding oral desmopressin. Based on this precipitous onset of DI crisis, we recommend not withholding desmopressin for more than 24 h. Abstract
Christian Kroll, Arya Zandvakili
wiley +1 more source
Veterinary Surgery, Volume 52, Issue 1, Page 69-80, January 2023., 2023 Abstract Objective To characterize the clinical features, neurological examination findings, diagnostic imaging results, histopathological findings, and outcome following transsphenoidal hypophysectomy (TSH) in dogs with nonfunctional sellar masses (NFSM). Study design Multi‐institutional retrospective study.
Brittany R. Hyde +6 more
wiley +1 more source
Desmopressin in nonsevere hemophilia A:patient perspectives on use and efficacy [PDF]
, 2023 Background: Desmopressin increases plasma factor VIII and von Willebrand factor levels in persons with nonsevere hemophilia A. Patients’ perspectives on desmopressin are relevant to increase and optimize its suboptimal use.
Coppens, Michiel +14 more
core +4 more sources
Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study [PDF]
, 2021 Background: Desmopressin orally disintegrating tablet (ODT) was approved in March 2012 in Japan; the post-market safety reports, which warned about adequate initial dose of desmopressin ODT, were published in 2014.
Harada, Norio +6 more
core +1 more source